Research Blog

January 10, 2020

Prostate Biomarkers: Prostate-Specific Antigen (PSA) Test

Optimal Takeaways

Prostate-specific antigen increases with prostate cancer and other prostate disorders, including benign prostatic hypertrophy. Increasing PSA in the blood likely indicates inflammation, tissue damage, and increased cancer risk. A low PSA suggests a low risk of prostate cancer.


Unlock Full Access to This Exclusive Content!

You’ve just scratched the surface. To dive deeper into this article and unlock our entire library of cutting-edge insights, clinical tools, webinars, and more, join Optimal DX today. With your membership, you'll gain full access to our powerful blood analysis software and a growing vault of expert content designed to enhance your practice and elevate patient care.

CLICK HERE to become a member and experience the full benefits of Optimal DX!

Tag(s): Biomarkers

Other posts you might be interested in